Loading...
Market
What will be the outcome of the House China Panel's investigation into GenScript by December 31, 2024?
5
China•FBI•ODNI•Chinese•GenScript•Chinese Communist Party•CCP•John Moolenaar•Raja Krishnamoorthi•Legend Biotech
Resolution / Starting Odds
No action • 25%
Sanctions recommended • 25%
Further investigation • 25%
Other actions • 25%
Official report or public announcement from House China Panel
Story
House China Panel Seeks FBI, ODNI Briefing on GenScript's CCP Links
May 31, 2024, 07:02 PM
The U.S. House of Representatives committee on China has requested a briefing from the FBI and the Office of the Director of National Intelligence (ODNI) on the activities of Chinese biotech firm GenScript and its connections to the Chinese Communist Party (CCP). The committee, led by Chairman Rep. John Moolenaar and Ranking Member Rep. Raja Krishnamoorthi, is particularly concerned about GenScript's role in establishing CCP-controlled chokepoints in critical areas of the biotechnology industry. This request marks an expansion of the committee's focus from contract research organizations (CROs) and national security to include therapeutics developers and commercial competitiveness, including Legend Biotech.
View original story
Similar markets
No action taken • 25%
Code of conduct recommended • 25%
Formal reprimand issued • 25%
Referral for further legal action • 25%
No significant action • 33%
Recommendations for sanctions • 33%
Formal charges against involved individuals • 34%
No significant action • 33%
Policy changes • 33%
Personnel changes • 33%
No wrongdoing found • 33%
Minor violations identified • 33%
Major violations identified • 33%
Fauci exonerated • 25%
Fauci reprimanded • 25%
Fauci faces legal action • 25%
Investigation inconclusive • 25%
No further action • 33%
Launch of a new investigation • 33%
Public reprimand or policy change • 33%
No actionable findings • 33%
Minor infractions found • 33%
Major violations found • 34%
No significant wrongdoing found • 33%
Minor policy violations • 33%
Major legal and ethical violations found • 34%
No violation found • 33%
Minor violations found • 33%
Major violations found • 33%
Fines imposed • 33%
Operations restricted • 33%
No penalties • 34%
No new investigation • 33%
Investigation finds significant omissions • 33%
Investigation finds no significant issues • 33%